Archive for 2005

  • Matsushita S., Honda A., Shibata, J., Kimura T., Ikeda, T., Koito, A., Yoshimura, K.: HIV-1 proviral DNA dynamics in patients with long-term successful HAART. 2nd International Workshop on HIV Persistence during Therapy. 12. 6-9, 2005, Saint Martin, FWI.

  • 池田輝政、柴田潤二、吉村和久、小糸厚、松下修三:長期間HAART有効症例における残存HIVとintegration siteの関連性. 第19回日本エイズ学会学術集会. 2005.12.1-3. 熊本.

  • 柴田潤二、吉村和久、前田洋助、村上俊夫、小糸厚、松下修三:広範囲HIV-1中和単クローン抗体のin vitro逃避ウイルスの誘導と解析. 第19回日本エイズ学会学術集会. 2005.12.1-3. 熊本.

  • 吉村和久、柴田潤二、池田輝政、小糸厚、松下修三:HAARTにより長期間ウイルスが抑制された症例のpDNAの推移. 第19回日本エイズ学会学術集会. 2005.12.1-3. 熊本.

  • 松下修三:シンポジウム-HIV/AIDSの臨床における最近の問題点-イントロダクションー.第19回日本エイズ学会学術集会.  2005.12.1-3. 熊本.

  • 柴田潤二、吉村和久、小糸 厚、松下修三 : ヒト免疫不全ウイルス1型gp120のC3領域変異による抗V3中和抗体に対する中和抵抗性の獲得. 第53回日本ウイルス学会総会、横浜、2005.11.20-22.

  • 柴田潤二、吉村和久、前田洋助、村上利夫、江田康幸、小糸厚、松下修三: 広範囲HIV-1単クローン抗体のin vitro逃避ウイルスの誘導と解析.第8回白馬シンポジウムin鹿児島-エイズ治療の最前線-.2005.11.3-4.鹿児島.

  • 松下修三:A broadly reactive neutralizing antibody and evolution of escape mutants in vitro. 第8回白馬シンポジウムin鹿児島?エイズ治療の最前線?.2005.11.3-4.鹿児島.

  • 柴田潤二、吉村和久、前田洋助、村上利夫、江田康幸、小糸厚、松下修三: 広範囲HIV-1単クローン抗体のin vitro逃避ウイルスの誘導と解析. 第6回熊本エイズセミナー. 2005.9.15. 熊本.

  • Ikeda, T., Shibata, J., Honda A., Yoshimura K., Koito, A., Matsushita, S.: Relationship of residual HIV-1 and the integration sites in patients on prolonged and effective HAART. International Symposium, The Cooperative research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases, 2005. 9.15-16. Kumamoto.

  • Shibata, J., Yoshimura K., Maeda, Y., Murakami, T., Eda. Y., Koito, A., Matsushita, S.: In vitro induction of human immunodeficiency virus type 1 variants resistant to a novel broad neutralizing anti-HIV monoclonal antibody, KD-247. International Symposium, The Cooperative research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases, 2005. 9.15-16. Kumamoto.

  • Yoshimura K., Shibata, J., Ikeda, T., Honda A., Koito, A., Matsushita, S.: HIV-1 proviral DNA dynamics in patients with long-term successful HAART. International Symposium, The Cooperative research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases, 2005. 9.15-16. Kumamoto.

  • Matsushita S., Shibata, J., Yoshimura, K., Maeda,Y., Murakami,T., Koito A, Honda, M., Mitsuya,H., Eda, Y. : Development of broadly reactive neutralizing monoclonal antibody KD247: implication for passive immunotherapy. The cooperative research project on clinical and epidemiological studies of emerging and re-emerging infectious diseases, Aso, Japan, Sep. 15-16, 2005.

  • Matsushita, S., Honda A., Kenai, A., Shibata, J., Koito, A., Yoshimura K.: Long-Term Follow-Up Study for the Change of the Reservoir for HIV-1 on Highly Active Antiretroviral Therapy. 7th International Congress on AIDS in Asia and the Pacific. 2005. 7. 1-5. Kobe.

  • Yoshimura K., Honda A., Kenai, A., Shibata, J., Koito, A., Matsushita, S.: Proviral DNA and Turnover Levels in Aviremic Long-Term Non-Progressors (LTNPs); A Temporary Goal forreactive neutralizing monoclonal antibody KD247: implicat5ions for passivePatients under HAART. 7th International Congress on AIDS in Asia and the Pacific. 2005. 7. 1-5. Kobe.児島.

  • Matsushita S., Yoshimura, K., Kimura T., Kamihira, A., Takano, M., Eto, K., Shirasaka, T., Mitsuya, H., Oka, S.: Spontaneous recovery of hemoglobin and neutrophil levels in Japanese patients on a long-term CombivirR containing regimen. J.Clin.Virol. 33:188-193, 2005

  • Sakaguchi N, Kimura T., Matsushita S, Fujimura S, Shibata J, Araki M, Sakamoto T, Minoda S, and Kuwahara K.Generation of high-affinity antibody against T cell- dependent antigen in ganp gene- transgenic mouse. J. Immunol. 174:4485-4494,2005.

  • Matsushita S, Takahama S., Shibata J., Kimura T., Shiozaki K., Eda Y., Koito A., Murakami T, and Yoshimura K. Ex vivo neutralization of HIV-1 quasispecies by a broadly reactive humanized monoclonal antibody KD247. Human Antibodies. 14:80-88, 2005